Barclays’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
Barclays's NXTC Position: Q3 2026 in Review
Barclays reduced its NextCure (NXTC) stake by 1.7% in Q3 2026, selling an estimated $540 and leaving 5,629 shares worth $28.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4692.
Barclays first reported a position in NXTC in Q2 2019 and has held it in 30 quarters since. The position peaked at $872K in Q4 2019. 33 funds tracked by Wall St. Rank hold NXTC as of Q3 2026.
- Barclays held 5,629 shares of NextCure worth $28.2K as of Q3 2026.
- Barclays sold 97 NextCure shares in Q3 2026, an estimated $540.
- NextCure made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4692 holding.
- Barclays first reported a position in NextCure in Q2 2019 and has held it in 30 quarters since.
- Barclays's NextCure position peaked at $872K in Q4 2019.
- 33 funds tracked by Wall St. Rank held NextCure as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.